CICC issued a research report indicating that during the '618' promotion period held by JushBio (02367.HK) from May 15th to June 20th this year, the total GMV of online transactions of Comfy and Collagen, two major brands, on various e-commerce platforms increased by over 60% and 100% respectively compared to the previous year, which is expected to lay a good foundation for Q2 performance. Accordingly, the adjusted profit forecast for this and next year will be increased by 5% each, to RMB 1.92 billion and 2.28 billion.

CICC pointed out that JushBio is a leading enterprise in the field of collagen reorganization in mainland China, and maintains an optimistic view of its future growth prospects, believing that the future growth prospects are predictable. The 'outperform industry' rating is maintained, and the target price is increased by 7.5% to 57 yuan, corresponding to a forecast P/E ratio of about 28 times and 23 times for this and next year respectively.